tiprankstipranks
Trending News
More News >

Argent BioPharma Launches EU-GMP Cannabinoid API Supply for Epilepsy Treatment in Slovenia

Story Highlights
  • Argent BioPharma starts EU-GMP cannabinoid API supply for epilepsy at Slovenia’s largest hospital.
  • This milestone enhances Argent’s market position and supports future EU and U.S. expansion.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Argent BioPharma Launches EU-GMP Cannabinoid API Supply for Epilepsy Treatment in Slovenia

Don’t Miss TipRanks’ Half-Year Sale

Argent Biopharma ( (AU:RGT) ) has provided an update.

Argent BioPharma has initiated the supply of EU-GMP cannabinoid-based active pharmaceutical ingredients (API) for epilepsy treatment at the University Medical Centre Ljubljana, Slovenia’s largest hospital. This follows a successful pilot program and marks a significant milestone in the company’s operations, enhancing its market position in Europe. The collaboration with Slovenian health authorities and the hospital demonstrates Argent’s leadership in cannabinoid regulations and expands its commercial opportunities within the EU. The initiative strengthens Argent’s Epilepsy Program Platform (EPP) and supports future EU and U.S. expansion, providing evidence-based treatment options for complex epilepsy cases.

More about Argent Biopharma

Argent BioPharma Ltd. (ASX: RGT) is a clinical-stage biopharmaceutical company specializing in nano-engineered therapeutics aimed at balancing the nervous and immune systems. The company’s primary products, CannEpil® and CimetrA®, focus on treating drug-resistant epilepsy and cytokine-driven inflammatory disorders. Argent BioPharma’s proprietary delivery technologies enhance drug penetration across critical barriers, supporting unique efficacy and protection. The company emphasizes urgent unmet needs in CNS and systemic inflammation, excluding oncology, and operates with integrated EU-GMP manufacturing and a Neuro-Immune Modulatory platform.

Average Trading Volume: 39,216

Technical Sentiment Signal: Sell

Current Market Cap: A$4.94M

For a thorough assessment of RGT stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1